Key result
Structural progression in arrhythmogenic cardiomyopathy was associated with a higher incidence of severe ventricular arrhythmic events.
Why the study?
The study aimed to evaluate structural progression and its impact on arrhythmic outcomes in arrhythmogenic cardiomyopathy patients and mutation-positive family members.
Cohort (n=144)
In arrhythmogenic cardiomyopathy, structural progression is similar between probands and family members and is strongly associated with severe ventricular arrhythmic events.
Answers are grounded in this paper and cite their sources.
May support intensified monitoring in arrhythmogenic cardiomyopathy with progression; leaves open prospective validation for risk stratification.
AIMS: We aimed to assess structural progression in arrhythmogenic cardiomyopathy (AC) patients and mutation-positive family members and its impact on arrhythmic outcome in a longitudinal cohort study. METHODS AND RESULTS: Structural progression was defined as the development of new Task Force imaging criteria from inclusion to follow-up and progression rates as annual changes in imaging parameters. We included 144 AC patients and family members (48% female, 47% probands, 40 ± 16 years old). At genetic diagnosis and inclusion, 58% of family members had penetrant AC disease. During 7.0 [inter-quartile range (IQR) 4.5-9.4] years of follow-up, 47% of family members without AC at inclusion developed AC criteria, resulting in a yearly new AC penetrance of 8%. Probands and family members had a similar progression rate of right ventricular outflow tract diameter (0.5 mm/year vs. 0.6 mm/year, P = 0.28) by mixed model analysis of 598 echocardiographic examinations. Right ventricular fractional area change progression rate was even higher in family members (-0.6%/year vs. -0.8%/year, P < 0.01). Among 86 patients without overt structural disease or arrhythmic history at inclusion, a first severe ventricular arrhythmic event occurred in 8 (9%), of which 7 (88%) had concomitant structural progression. Structural progression was associated with higher incidence of severe ventricular arrhythmic events adjusted for age, sex, and proband status (HR 21.24, 95% CI 2.47-182.81, P < 0.01). CONCLUSION: More than half of family members had AC criteria at genetic diagnosis and yearly AC penetrance was 8%. Structural progression was similar in probands and family members and was associated with higher incidence of severe ventricular arrhythmic events.
No takes yet. Share an insight, caveat, or question.
Chivulescu et al. (2019) conducted a cohort in Arrhythmogenic cardiomyopathy (n=144). Structural progression vs. No structural progression was evaluated on Severe ventricular arrhythmic events (HR 21.24, 95% CI 2.47-182.81, p=< 0.01). Structural progression in arrhythmogenic cardiomyopathy was associated with a higher incidence of severe ventricular arrhythmic events.
Synapse has enriched 10 related papers. Consider them for comparative context: